Sulindac, a non-steroidal anti-inflammatory drug, mediates breast cancer inhibition as an immune modulator.

Yin, Tao

Sulindac, a non-steroidal anti-inflammatory drug, mediates breast cancer inhibition as an immune modulator. [electronic resource] - Scientific reports Jan 2016 - 19534 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

2045-2322

10.1038/srep19534 doi


Adaptive Immunity--drug effects
Animals
Anti-Inflammatory Agents, Non-Steroidal--pharmacology
Breast Neoplasms--drug therapy
Cell Line, Tumor
Cytokines--metabolism
Disease Models, Animal
Humans
Immunologic Factors--pharmacology
Immunomodulation--drug effects
Inflammation Mediators--metabolism
Lymphocyte Depletion
Macrophages--drug effects
Mice
Neoplasm Metastasis
Neovascularization, Pathologic
Sulindac--pharmacology
T-Lymphocyte Subsets--drug effects
Tumor Burden--drug effects
Tumor Microenvironment--drug effects